Exposure to dim light at night, which is common in today’s lifestyle, may contribute to the spread of breast cancer to the bones, researchers have shown for the first time in an animal study. Results of the study will be presented Saturday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La. “To […]Continue Reading ...
A new study reveals that preventive medications–such as those to lower blood pressure or cholesterol, or to protect bone health, among others–are commonly prescribed during the last year of life of older adults with cancer, even though they are unlikely to provide meaningful benefits. Published early online in CANCER, a peer-reviewed journal of the American […]Continue Reading ...
Unlike the three most common forms of breast cancer, triple negative breast cancer has no currently approved targeted therapies for treatment. That was one of the reasons it was chosen as a disease area of focus for the Indiana University Precision Health Grand Challenge initiative, aimed to research and develop better treatments, cures or preventions, […]Continue Reading ...
Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. The study, published March 22 in the print issue of Science, shows how high-fructose corn syrup fuels the growth of colon tumors in these […]Continue Reading ...
This month’s edition of Drug Discovery Today, Editor’s Choice returns to more familiar ground from last month’s excursion into regulatory issues, with 3 excellent articles on various aspects of drug discovery targeted at the treatment of cancer. The war on cancer has been a constant battle since the early 1970s as championed by Senator […]Continue Reading ...
Ludwig Cancer Research released today the full breadth of findings to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Ga., March 29 – April 3, 2019. Research conducted by more than 75 Ludwig scientists will be shared in plenary sessions, major symposiums, education sessions, poster […]Continue Reading ...
FINDINGS Researchers from UCLA’s Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world’s deadliest cancers. The combination approach uses one drug that inhibits the process — known as lysosome — that allows cancer cells to recycle essential nutrients to […]Continue Reading ...
Researchers at the University of Milan have predicted that death rates from breast cancer will fall this year in all European Union (EU) countries, with the exception of Poland. Shutterstock | New Africa According to annual predictions by Carlo La Vecchia and colleagues, death rates from breast cancer will fall by almost nine percent across […]Continue Reading ...
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy. In a Nature Communications paper published today, researchers reveal for the first time that the number of mitochondria in a cell is, in great part, associated with how the […]Continue Reading ...
By any measure, lung cancer patients have it rough. But Maryland resident and special education teacher Montessa Lee has been through a particularly arduous ordeal. In September 2006, she experienced pain in her rib cage and sought medical care. Told she had inflammation, she was given medicine for her pain. But the pain returned. At […]Continue Reading ...
Spencer Hoover, vice president and executive director of the Henry Ford Cancer Institute, is co-author of a manuscript published in the Journal of Oncology Practice aimed at establishing best practices to promote diversity in clinical trials. In-depth interviews were conducted with leaders from U.S. cancer centers with above average recruitment of racial and ethnic minority […]Continue Reading ...
City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research (AACR) annual meeting from March 29 through April 3 in Atlanta. More than 22,500 […]Continue Reading ...
In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which […]Continue Reading ...
South San Francisco, CA — March 18, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of adults with extensive-stage small cell lung cancer (ES-SCLC). […]Continue Reading ...
A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing. The Cancer Research UK and Wellcome Trust funded study, published in the journal Cancer Cell, showed that the drugs, called PARG inhibitors, can kill ovarian cancer cells by targeting weaknesses […]Continue Reading ...
- Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
- Personal context directly affects CPAP use
- Mosquito tracking key to preventing disease outbreaks
- Scientists Detect Hidden Signals from Beneficial Bacteria
- Treating women with thyroid antibodies with Levothyroxine do not increase live birth rate
- Brain area that only processes spoken, not written words identified
- Race and ethnicity influence fracture risk in diabetic patients
- Researchers report new regenerative medicine approach for treating osteoarthritis of the knee
- Exposure to dim light at night may contribute to spread of breast cancer to bones
- Benefits of osteoporosis treatment in postmenopausal women outweigh the perceived risks
- Researchers find evidence of Cryptosporidium parasite in Minnesota’s public water systems
- Three Clues to Raised Risk of Miscarriage
- Structured play helps toddlers self-regulate, altering their life course
- Translating horror into justice: Stanford psychiatrist advocates for human rights
- HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range
- Recurrent pregnancy loss may be caused by sperm DNA damage, finds study
- Special Collection tracks development of new diagnostic tests for tuberculosis
- Air Force develops genetic test to predict mental performance
- To abort or not to abort—making difficult choices alone
- Computer vision technology could aid ICU care by spotting movement